Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Kaletra 100mg/25mg tablets
0503010G0BBADAD
|
Kaletra | Lopinavir and ritonavir | Infections | No data available |
|
Kaletra 133.3mg/33.3mg capsules
0503010G0BBAAAA
|
Kaletra | Lopinavir and ritonavir | Infections | No data available |
|
Kaletra 200mg/50mg tablets
0503010G0BBACAC
|
Kaletra | Lopinavir and ritonavir | Infections | No data available |
|
Kaletra 80mg/20mg/1ml oral solution
0503010G0BBABAB
|
Kaletra | Lopinavir and ritonavir | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.